Sizing Up Pneumonia Research

Click here for the full report (approx 60mb file, pdf format). Published 19 April 2018.

This report summarises public and philanthropic funding for pneumonia-related research by the G20 countries between 2000 and 2015 and provides detail of findings in specific areas: funding for diagnosis, therapeutics and vaccine research, research with a focus on the paediatric community, antimicrobial resistance, and funding of pneumonia research in high-risk areas.

The analyses presented here form part of the most comprehensive data set of global investments in infection-related research undertaken to date. Overall, volume of research into pneumonia is lower than is warranted by its burden of disease when compared to other high-burden infectious diseases such as HIV, tuberculosis, and malaria.

Suggested citation – : Research Investments in Global Health Study (ResIn). Sizing up Pneumonia Research: Assessing Global Investments in Pneumonia Research 2000 – 2015. Southampton, UK. 2018. https://doi.org/10.6084/m9.figshare.6143060.v1 

Figure 1 pneumonia infographic Figure 2 pneumonia infographic

 

 

 

 

 

 

 

 

 

 

 

 

Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook

Recent updates

  • ResIn podcast now online!

  • ResIn project lead, Dr Michael Head, has recorded a podcast with the Public Policy@Southampton group. The second episode of their ‘Policy Pod’ series, Michael discusses with them the evolution of the ResIn study and how to influence and engage with policymakers.

    Fancy a listen?! Click here to hear the Policy Pod. Follow Public Policy@Southampton on Twitter at @PublicPolicyUoS.

     

     

     

    Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook
  • Global funding analysis of R&D investments for pneumonia!

  • We are delighted to publish new findings from the Research Investments in Global Health study, hosted by the University of Southampton and funded by the Bill & Melinda Gates Foundation. The report, entitled ‘Sizing up pneumonia research’ summarises public and philanthropic investment for pneumonia-related research by the G20 countries between 2000 and 2015. It provides analysis of investment trends over time, the geography of pneumonia research funding, and levels of investment in specific priority areas such as paediatric, antimicrobial resistance and vaccine-focused research.

    Overall, $3 billion of pneumonia-related research investment is described here, covering over 2000 studies from dozens of different funders. Despite the very high mortality (almost 1 million deaths per year, mostly in children aged under 5 in resource-poor settings), the volume of research into pneumonia is low, and the ‘Big Three’ of HIV, malaria and tuberculosis all receive greater levels of funding compared to their respective burden of disease. Pneumonia has been historically neglected by the global health community, and it’s time for that to change. Our analyses inform the evidence base around resource allocation and provide a platform for further multi-disciplinary stakeholder discussions including policymakers, funders, researchers and clinicians.

    See http://researchinvestments.org/pneumonia/ for the full report.

    Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook
  • An afternoon of global health with ResIn and RSTMH

  • Free event – An afternoon of global health with ResIn and RSTMH
    Monday 18 September, 3:15pm – 4:45pm
    University of Southampton, Highfield Campus
    All welcome!

    Click here to register

    Preceded by a brief introduction from Professor David Wilson, Associate Dean for Internationalisation, this event will include two talks –

    a) Royal Society of Tropical Medicine and Hygiene Strategy Launch – RSTMH Chief Executive, Tamar Ghosh, will present the Society’s new strategy, including information about several new activities including mentoring, education and training. There will also be time to discuss the benefits of RSTMH membership which include journal access, a calendar of scientific and social events, plus a well-established grants round.

    b) Presentation of the results of the Southampton-led Research Investments in Global Health Study (ResIn).
    Funded by the Bill & Melinda Gates Foundation and enthusiastically received by (among others) the World Health Organisation, Dr’s Michael Head and Rebecca Brown have analysed 16 years of data on global infectious disease funding. How much funding goes to HIV research compared to tuberculosis? Is pneumonia an under-funded and neglected area? What does the research landscape look like for malaria investments in sub-Saharan Africa? What can we learn from the historical financing of research for Ebola? What should the research landscape look like going forward, and how should we in the global health community be setting future priorities?

    This event is open to colleagues both within the University of Southampton and externally. Everybody is welcome!

    Location – Senate Room, 4th floor, building 37, Highfield campus of the University of Southampton.

    Webpage to register – https://www.eventbrite.co.uk/e/an-afternoon-of-global-health-with-resin-and-rstmh-tickets-36099988036

    Click here for a pdf flyer of the event. 

    Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook